메뉴 건너뛰기




Volumn 7, Issue , 2013, Pages 951-960

Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine

Author keywords

Clinical outcomes; Diabetes mellitus; Insulin glargine; Premixed insulin; Rapid acting insulin; Treatment persistence; Type 2

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE; ANGIOTENSIN RECEPTOR ANTAGONIST; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; MEGLITINIDE; METFORMIN; SULFONYLUREA;

EID: 84884728188     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S49287     Document Type: Article
Times cited : (12)

References (35)
  • 1
    • 78650454230 scopus 로고    scopus 로고
    • Add-on therapies to metformin for type 2 diabetes
    • Shomali M. Add-on therapies to metformin for type 2 diabetes. Expert Opin Pharmacother. 2011;12(1):47-62.
    • (2011) Expert Opin Pharmacother , vol.12 , Issue.1 , pp. 47-62
    • Shomali, M.1
  • 2
    • 0036483958 scopus 로고    scopus 로고
    • Sulfonylurea inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)
    • Wright A, Burden AC, Paisey RB, Cull CA, Holman RR. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57). Diabetes Care. 2002;25(2):330-336.
    • (2002) Diabetes Care , vol.25 , Issue.2 , pp. 330-336
    • Wright, A.1    Burden, A.C.2    Paisey, R.B.3    Cull, C.A.4    Holman, R.R.5
  • 3
    • 84864285795 scopus 로고    scopus 로고
    • Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    • Inzucchi SE, Bergenstal RM, Buse JB, etal. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55(6):1577-1596.
    • (2012) Diabetologia , vol.55 , Issue.6 , pp. 1577-1596
    • Inzucchi, S.E.1    Bergenstal, R.M.2    Buse, J.B.3
  • 4
    • 84855185039 scopus 로고    scopus 로고
    • Standards of medical care in diabetes-2012
    • American Diabetes Association (ADA)
    • American Diabetes Association (ADA). Standards of medical care in diabetes-2012. Diabetes Care. 2012;35 Suppl 1:S11-S63.
    • (2012) Diabetes Care , vol.35 , Issue.SUPPL. 1
  • 5
    • 80053385824 scopus 로고    scopus 로고
    • Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: A 6-month 'proof-of-concept' study
    • Owens DR, Luzio SD, Sert-Langeron C, Riddle MC. Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study. Diabetes Obes Metab. 2011;13(11): 1020-1027.
    • (2011) Diabetes Obes Metab , vol.13 , Issue.11 , pp. 1020-1027
    • Owens, D.R.1    Luzio, S.D.2    Sert-Langeron, C.3    Riddle, M.C.4
  • 6
    • 12844265257 scopus 로고    scopus 로고
    • Initiating insulin therapy in type 2 diabetes: A comparison of biphasic and basal insulin analogs
    • Raskin P, Allen E, Hollander P, etal. Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care. 2005;28(2):260-265.
    • (2005) Diabetes Care , vol.28 , Issue.2 , pp. 260-265
    • Raskin, P.1    Allen, E.2    Hollander, P.3
  • 9
    • 77951047546 scopus 로고    scopus 로고
    • Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs
    • Peyrot M, Rubin RR, Polonsky WH, Best JH. Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs. Curr Med Res Opin. 2010;26(5):1047-1054.
    • (2010) Curr Med Res Opin , vol.26 , Issue.5 , pp. 1047-1054
    • Peyrot, M.1    Rubin, R.R.2    Polonsky, W.H.3    Best, J.H.4
  • 10
    • 73349140858 scopus 로고    scopus 로고
    • Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study
    • Fritsche A, Larbig M, Owens D, Häring HU. Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study. Diabetes Obes Metab. 2010;12(2):115-123.
    • (2010) Diabetes Obes Metab , vol.12 , Issue.2 , pp. 115-123
    • Fritsche, A.1    Larbig, M.2    Owens, D.3    Häring, H.U.4
  • 11
    • 35548947584 scopus 로고    scopus 로고
    • Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes
    • Holman RR, Thorne KI, Farmer AJ, etal. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med. 2007;357(17):1716-1730.
    • (2007) N Engl J Med , vol.357 , Issue.17 , pp. 1716-1730
    • Holman, R.R.1    Thorne, K.I.2    Farmer, A.J.3
  • 12
    • 70350534273 scopus 로고    scopus 로고
    • Three-year efficacy of complex insulin regimens in type 2 diabetes
    • Holman RR, Farmer AJ, Davies MJ, etal. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med. 2009;361(18): 1736-1747.
    • (2009) N Engl J Med , vol.361 , Issue.18 , pp. 1736-1747
    • Holman, R.R.1    Farmer, A.J.2    Davies, M.J.3
  • 13
    • 39449106869 scopus 로고    scopus 로고
    • Efficacy and treatment satisfaction of once-daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with type 2 diabetes previously on long-term conventional insulin therapy: The SWITCH Pilot Study
    • Schiel R, Müller UA. Efficacy and treatment satisfaction of once-daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with type 2 diabetes previously on long-term conventional insulin therapy: the SWITCH Pilot Study. Exp Clin Endocrinol Diabetes. 2008;116(1):58-64.
    • (2008) Exp Clin Endocrinol Diabetes , vol.116 , Issue.1 , pp. 58-64
    • Schiel, R.1    Müller, U.A.2
  • 14
    • 84865067095 scopus 로고    scopus 로고
    • Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: The SWING study
    • Reaney M, Cypryk K, Tentolouris N, etal. Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: the SWING study. Diabetes Res Clin Pract. 2012;97(2):231-241.
    • (2012) Diabetes Res Clin Pract , vol.97 , Issue.2 , pp. 231-241
    • Reaney, M.1    Cypryk, K.2    Tentolouris, N.3
  • 15
    • 38349101301 scopus 로고    scopus 로고
    • Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies
    • Davies M, Sinnassamy P, Storms F, Gomis R. Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies. Diabetes Res Clin Pract. 2008;79(2):368-375.
    • (2008) Diabetes Res Clin Pract , vol.79 , Issue.2 , pp. 368-375
    • Davies, M.1    Sinnassamy, P.2    Storms, F.3    Gomis, R.4
  • 16
    • 84877738609 scopus 로고    scopus 로고
    • Are current clinical trials in diabetes addressing important issues in diabetes care?
    • Lakey WC, Barnard K, Batch BC, Chiswell K, Tasneem A, Green JB. Are current clinical trials in diabetes addressing important issues in diabetes care? Diabetologia. 2013;56(6):1226-1235.
    • (2013) Diabetologia , vol.56 , Issue.6 , pp. 1226-1235
    • Lakey, W.C.1    Barnard, K.2    Batch, B.C.3    Chiswell, K.4    Tasneem, A.5    Green, J.B.6
  • 17
    • 0034702175 scopus 로고    scopus 로고
    • Randomized, controlled trials, observational studies, and the hierarchy of research designs
    • Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):1887-1892.
    • (2000) N Engl J Med , vol.342 , Issue.25 , pp. 1887-1892
    • Concato, J.1    Shah, N.2    Horwitz, R.I.3
  • 18
    • 35948970944 scopus 로고    scopus 로고
    • Patients with type 2 diabetes inadequately controlled on premixed insulin: Effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice
    • Hammer H, Klinge A. Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice. Int J Clin Pract. 2007;61(12):2009-2018.
    • (2007) Int J Clin Pract , vol.61 , Issue.12 , pp. 2009-2018
    • Hammer, H.1    Klinge, A.2
  • 19
    • 61649113766 scopus 로고    scopus 로고
    • Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: A retrospective primary-care-based analysis
    • Sharplin P, Gordon J, Peters JR, Tetlow AP, Longman AJ, McEwan P. Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis. Cardiovasc Diabetol. 2009;8:9.
    • (2009) Cardiovasc Diabetol , vol.8 , pp. 9
    • Sharplin, P.1    Gordon, J.2    Peters, J.R.3    Tetlow, A.P.4    Longman, A.J.5    McEwan, P.6
  • 20
    • 84862686725 scopus 로고    scopus 로고
    • Optimization of insulin therapy in patients with type 2 diabetes mellitus: Beyond basal insulin
    • Blak BT, Smith HT, Hards M, Curtis BH, Ivanyi T. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin. Diabet Med. 2012;29(7):e13-e20.
    • (2012) Diabet Med , vol.29 , Issue.7
    • Blak, B.T.1    Smith, H.T.2    Hards, M.3    Curtis, B.H.4    Ivanyi, T.5
  • 21
    • 77953027133 scopus 로고    scopus 로고
    • Assessment of adherence and healthcare costs costs of insulin device (FlexPen®) versus conventional vial/syringe
    • Baser O, Bouchard J, DeLuzio T, Henk H, Aagren M. Assessment of adherence and healthcare costs costs of insulin device (FlexPen®) versus conventional vial/syringe. Adv Ther. 2010;27(2):94-104.
    • (2010) Adv Ther , vol.27 , Issue.2 , pp. 94-104
    • Baser, O.1    Bouchard, J.2    DeLuzio, T.3    Henk, H.4    Aagren, M.5
  • 22
    • 84884714255 scopus 로고    scopus 로고
    • National Committee for Quality Assurance, Available from, Accessed July 19 2013
    • National Committee for Quality Assurance. HEDIS 2013. Available from: http://www.ncqa.org/HEDISQualityMeasurement/HEDISMeasures/HEDIS2013.aspx. Accessed July 19, 2013.
    • HEDIS 2013
  • 23
    • 77955096791 scopus 로고    scopus 로고
    • Validating ICD coding algorithms for diabetes mellitus from administrative data
    • Chen G, Khan N, Walker R, Quan H. Validating ICD coding algorithms for diabetes mellitus from administrative data. Diabetes Res Clin Pract. 2010;89(2):189-195.
    • (2010) Diabetes Res Clin Pract , vol.89 , Issue.2 , pp. 189-195
    • Chen, G.1    Khan, N.2    Walker, R.3    Quan, H.4
  • 24
    • 84855846339 scopus 로고    scopus 로고
    • Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care setting
    • Davis SN, Wei W, Garg S. Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care setting. Endocr Pract. 2011;17(6): 845-852.
    • (2011) Endocr Pract , vol.17 , Issue.6 , pp. 845-852
    • Davis, S.N.1    Wei, W.2    Garg, S.3
  • 25
    • 84875205714 scopus 로고    scopus 로고
    • Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus
    • Xie L, Zhou S, Wei W, Gill J, Pan C, Baser O. Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus. Diabetes Technol Ther. 2013;15(3):230-236.
    • (2013) Diabetes Technol Ther , vol.15 , Issue.3 , pp. 230-236
    • Xie, L.1    Zhou, S.2    Wei, W.3    Gill, J.4    Pan, C.5    Baser, O.6
  • 26
    • 82355180949 scopus 로고    scopus 로고
    • A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens
    • Xie L, Wei W, Pan C, Du J, Baser O. A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens. Adv Ther. 2011;28(11):1000-1011.
    • (2011) Adv Ther , vol.28 , Issue.11 , pp. 1000-1011
    • Xie, L.1    Wei, W.2    Pan, C.3    Du, J.4    Baser, O.5
  • 27
    • 81255124243 scopus 로고    scopus 로고
    • Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID
    • Baser O, Wei W, Baser E, Xie L. Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID. J Med Econ. 2011;14(6):673-680.
    • (2011) J Med Econ , vol.14 , Issue.6 , pp. 673-680
    • Baser, O.1    Wei, W.2    Baser, E.3    Xie, L.4
  • 28
    • 84863230184 scopus 로고    scopus 로고
    • Combination therapy with insulin glargine and exenatide: Real-world outcomes in patients with type 2 diabetes
    • Levin P, Wei W, Wang L, Pan C, Douglas D, Baser O. Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes. Curr Med Res Opin. 2012;28(3): 439-446.
    • (2012) Curr Med Res Opin , vol.28 , Issue.3 , pp. 439-446
    • Levin, P.1    Wei, W.2    Wang, L.3    Pan, C.4    Douglas, D.5    Baser, O.6
  • 29
    • 84862108594 scopus 로고    scopus 로고
    • Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes
    • Zhao Y, Campbell CR, Fonseca V, Shi L. Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes. Diabetes Care. 2012;35(5):1126-1132.
    • (2012) Diabetes Care , vol.35 , Issue.5 , pp. 1126-1132
    • Zhao, Y.1    Campbell, C.R.2    Fonseca, V.3    Shi, L.4
  • 30
    • 77951622706 scopus 로고
    • The central role of the propensity score in observational studies for causal effects
    • Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1): 41-55.
    • (1983) Biometrika , vol.70 , Issue.1 , pp. 41-55
    • Rosenbaum, P.R.1    Rubin, D.B.2
  • 31
    • 38549098101 scopus 로고    scopus 로고
    • Medication compliance and persistence: Terminology and definitions
    • Cramer JA, Roy A, Burrell A, etal. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1): 44-47.
    • (2008) Value Health , vol.11 , Issue.1 , pp. 44-47
    • Cramer, J.A.1    Roy, A.2    Burrell, A.3
  • 32
    • 84886087279 scopus 로고    scopus 로고
    • Patient reported outcomes using twice-daily insulin aspart premixed vs insulin glargine plus 1 prandial insulin glulisine or step-wise addition of glulisine to glargine in type 2 diabetes uncontrolled with oral agents [abstract]
    • Polonsky WH, Rosenstock J, Gilmore AS, Wei W, Chaudhs SL, Riddle MC. Patient reported outcomes using twice-daily insulin aspart premixed vs insulin glargine plus 1 prandial insulin glulisine or step-wise addition of glulisine to glargine in type 2 diabetes uncontrolled with oral agents [abstract]. Diabetes. 2011;60 Suppl 1:A616.
    • (2011) Diabetes , vol.60 , Issue.SUPPL. 1
    • Polonsky, W.H.1    Rosenstock, J.2    Gilmore, A.S.3    Wei, W.4    Chaudhs, S.L.5    Riddle, M.C.6
  • 33
    • 78349266799 scopus 로고    scopus 로고
    • A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: An observational database study
    • Gordon J, Pockett RD, Tetlow AP, McEwan P, Home PD. A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study. Int J Clin Pract. 2010;64(12):1609-1618.
    • (2010) Int J Clin Pract , vol.64 , Issue.12 , pp. 1609-1618
    • Gordon, J.1    Pockett, R.D.2    Tetlow, A.P.3    McEwan, P.4    Home, P.D.5
  • 35
    • 38449093271 scopus 로고    scopus 로고
    • Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: An evidence-based comparison
    • Ilag LL, Kerr L. Malone JK, Tan MH. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison. Clin Ther. 2007;29(6 Pt 1):1254-1270.
    • (2007) Clin Ther , vol.29 , Issue.6 PART 1 , pp. 1254-1270
    • Ilag, L.L.1    Kerr, L.2    Malone, J.K.3    Tan, M.H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.